Clinical Trials Logo

Clinical Trial Summary

The subjects with MetS or type 2 diabetes were enrolled for this exercise-training program. All participators underwent an indoor bicycle exercise for twelve weeks. In addition to demographic data and biochemical tests were determined after an overnight fasting. Extension of muscle strength was detected in the dominant lower extremity.


Clinical Trial Description

This prospective open-labeled study was conducted in Taichung Veterans General Hospital. The adult participants with metabolic syndrome and/or type 2 diabetes were enrolled. MetS. The procedures were fully explained to all subjects before the cardiopulmonary exercise test. ll enrolled subjects received a scheduled twelve-week program for exercise-training program. A commercially available bicycle with an indoor bicycle trainer are used as the home exercise training modality. All medications were not allowed to be changed during the study. ;


Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02268292
Study type Interventional
Source Taichung Veterans General Hospital
Contact
Status Completed
Phase Phase 4
Start date August 2012
Completion date August 2014

See also
  Status Clinical Trial Phase
Terminated NCT02077179 - Health Improvement After Pregnancy (HIP) Program Randomized Control Trial N/A
Active, not recruiting NCT05843682 - Technological Innovation in the Virtual Assistance of Patients With Uncontrolled Arterial Hypertension - Hyper 2 N/A
Completed NCT00943254 - Metabolic Syndrome Diagnosis and Education Trial N/A
Completed NCT01408667 - Hyperinsulinemic Euglycemic Clamp Protocol Phase 1/Phase 2
Unknown status NCT01826357 - Cluster Analysis of the Risk of Metabolic Syndrome in Women for Reproductive Age N/A
Completed NCT02151227 - Magnesium and Metabolic Syndrome: A Dose-response Meta-analysis N/A
Completed NCT02460445 - Phlebotomy and Polycystic Ovary Syndrome N/A
Recruiting NCT02646475 - Metabolic Effects of Angiotensin-(1-7) Phase 1